Viewing insider transactions for Atomo Diagnostics Limited's (ASX:AT1 ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders ...

Atomo Diagnostics Ltd. (AU:AT1) has released an update. Atomo Diagnostics Ltd. is actively expanding its rapid diagnostic testing technologies, bolstered by a new Federal Government grant to develop a ...

SYDNEY–(BUSINESS WIRE)–Medical device innovator Atomo Diagnostics today announced it had raised A$4.5 million in new equity funding from a number of professional investors including the New York-based ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Medical device innovator Atomo Diagnostics today announced it is the recipient of a US$2.6 million (A$3.6 million) grant from the Bill & Melinda Gates Foundation to develop a next-generation HIV ...

PERTH, Australia – Australia’s Atomo Diagnostics Pty. Ltd. is preparing to raise AU$30 million (US$11.7 million) in an initial public offering on Australia’s Securities Exchange (ASX) that will enable ...

SYDNEY--(BUSINESS WIRE)--Medical device innovator Atomo Diagnostics today announced it had raised A$4.5 million in new equity funding from a number of professional investors including the New ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from Atomo ...

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body. The ...

Atomo Diagnostics Ltd (ASX:AT1) released its Q2 FY26 quarterly presentation on January 28, 2026, highlighting substantial revenue growth and strategic expansion initiatives. The company, which ...

NEW YORK, April 16, 2020 /PRNewswire/ -- The Global Health Investment Fund (GHIF) announced today that its portfolio company Atomo Diagnostics Limited (ASX: AT1) has commenced trading on the ...